Login to Your Account

Protecting Blood, Fighting Cancer, in the Liver

Radioprotective Entolimod Broadly Protective in Liver

By Anette Breindl
Science Editor

Friday, May 3, 2013

Researchers have discovered that the TLR5 agonist Entolimod (CBLB502, Cleveland BioLabs Inc.), which is in development as a radioprotective agent, work primarily on receptors in the liver, and that it may be useful to fight liver metastases and, more broadly, as a liver-protective agent.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription